Villanueva-Nájera MA, Miranda-Saucedo M, Prado-Serrano A

Idioma: Español
Referencias bibliográficas: 28
Paginas: 304-309
Archivo PDF: 0. Kb.

RESUMEN

El linfoma conjuntival es una rara entidad, se presenta en pacientes ancianos como una tumoración de color salmón, asintomática, en el fondo de saco o en la región perilimbar. La mayor incidencia está entre la sexta y séptima décadas de la vida. Se presenta el caso de un linfoma primario conjuntival de ojo izquierdo con lesión color salmón sobreelevada en conjuntiva nasal. La biopsia quirúrgica incisional con estudio histológico e inmunohistoquímico confirmó el diagnóstico de linfoma B de bajo grado de malignidad (tipo MALT). Se realizó estudio sistémico para descartar afección extranodal, siendo negativo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Isaacson PG, Müller-Hermelink HK, Piris MA, Berger F, Nathwani BN, Swerdlow SH y colsl. Extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue (MALT lymphoma). En: World Health Organization Classification of Tumours: Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman W (Eds). IARC Press. Lyon, 2001, pp 157-160.

2. Campo E, Chott A, Kinney MC, Leoncini L, Meijer CJ, Papadimintriou CS y cols. Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology 2006; 48:481-504.

3. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues.Lyon. WHO, 2001, p.157-160.

4. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology 2005; 128;1579-1605.

5. .5. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Eng J Med 2004; 350:213-215.

6. Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell’Oro S, Fleischhauer K y cols. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96:586-594.

7. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M y cols. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87:299-307.

8. Isaacson PG, Du Ming-Qing. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 2005; 255-274.

9. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, y cols. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001; 61:8820-8829.

10. Barrans SL, Fenton JA, Banham A, Owen RG, Jack AS. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004; 104:2933-2935.

11. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G y cols. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103:275-282.

12. Jereb B, Lee H, Jakobiec F, Kutcher J. Radiation therapy of conjunctival and orbital lymphoid tumors. Int J Radiat Oncol Biol Phys 1984; 10 (7):1013-1019.

13. Dunbar S, Linggood R, Doppke K, Duby A, Wang C. Conjunctival lymphoma: results and treatment with a single anterior electron field. A lens sparing approach. Int J Radiat Oncol Biol Phys 1990; 19(2):249-257.

14. Eichler M, Fraunfelder F. Cryotherapy for conjuntival lymphoid tumors. Am J Ophthalmol 1994; 118(4):63-67.

15. Kostas V, Vogiatzis M. Lymphoid tumors of the orbit and ocular adnexa: a long term follow up. Ann Ophtahmol 1984; 16 (11):1046-1055.

16. Skarin A, Dorfman D. Non Hodgkin lymphomas: current classification and managemet. Cancer J Clin 1997; 47:351-372.

17. Knowles D, Jakobiec F. Ocular adnexal lymphoid neoplasms: clinical, histopathologic, electron microscopics, and inmunologic characteristics. Hum Patho 1982; 13(2):148-162.

18. Medeiros J, Strickler J, Picker L, Gelb A, Weiss L, Warnke R. Well differentiated lymphocytic neoplasms inmunologic fin digs correlated with clinical presentation and morphologic features. Am J Pathol 1987; 129(3):523-534.

19. Coupland S, Krause L, Delecluse H, Anagnostopoulos I, Foss H, Hummel M y cols. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmol 1998; 105(8):1430-1441.

20. Laucirica R, Font RL. Cytologic evaluation of lymphoproliferative lesions of the orbit/ocular adnesa: an analysis of 46 cases. Diagn Cytopathol 1996; 15(3):241-245.

21. White WL, Ferry JA, Harris NL, Grove AS. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas mucosa-associated lymphoid tissue type. Ophthalmology 1995; 102(12):1994-2006.

22. Vose JM, Chiu BC, Cheson BD, Dancey J, Wright J. Update on epidemiology and therapeutics for Non-Hodgkin’s lymphoma. Hematology 2002; 241-262.

23. Kawamoto K, Miyanaga Y, Toriyama S. A case of bilateral MALT (mucosa-associated lymphoid tissue) type conjunctival malignant lymphoma. Nippon Ganka Gakkai Zasshi 1996; 100(3):246-252.

24. Pelegrín F. Tresserra O. Gris: Hiperplasia Benigna Linfoide Conjuntival. Annals d’Oftalmologia 2006; 14(3):169-171.

25. Di Bari PE, Martinez Bernal M. Linfoma B marginal extranodal bilateral tipo MALT de conjuntiva. Medico Oftalmólogo, Marzo 2007;14-16.

26. Jakobiec F, Knowles D. An overview of ocular adnexa lymphoid tumors. Trans Am Ophthalmol Soc 1989; 87:420-442.

27. Reiser M, Josting A, Diehl V, Engert A. Primary lymphoma of the conjunctiva a rare manifestation of indolent non- Hodgkin’s lymphoma. Ann Hematol 2001; 80(5):311-313.

28. Al-Muammar A, Hodge WG, Farmer J. Conjunctival T-cell lymphoma: a clinicopathologic case report. Ophthalmology 2006; 113(3):459-461.